Is there a third heart beta-adrenoceptor?

Area of Science:

• Pharmacology
• Cardiovascular Physiology
• Adrenoceptor Biology

Background:

• Partial agonists targeting myocardial beta-1 and beta-2 adrenoceptors can induce stimulant effects.
• These stimulant effects persist despite blockade of beta-1 and beta-2 adrenoceptors.

Purpose of the Study:

• To investigate the mechanism behind stimulant effects of partial agonists in the heart that are resistant to beta-1 and beta-2 adrenoceptor blockade.
• To explore the potential involvement of a novel adrenoceptor subtype in mediating these effects.

Main Methods:

• Investigated the effects of various partial agonists on myocardial tissue.
• Compared concentrations of partial agonists required for blockade versus stimulation.
• Examined structural similarities between the proposed novel receptor and known beta-3 adrenoceptors.

Main Results:

• Stimulant effects were observed at concentrations exceeding those required for receptor blockade.
• These effects were resistant to established beta-1 and beta-2 adrenoceptor antagonists.
• The characteristics of the novel receptor align with those of the beta-3 adrenoceptor.

Conclusions:

• Non-conventional partial agonists, such as pindolol analogues, may activate a third beta-adrenoceptor in the heart.
• This putative receptor shares similarities with the beta-3 adrenoceptor found in other tissues.
• Suggests a new target for understanding cardiac adrenergic signaling.